2DS-12763-86615
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Survey response — day 0, dose 1MedDRA: Pain in extremity, Self-medication — Feeling: Good · Site: PainFree text: Arm pain was somewhere between mild and moderate but very treatable with ibuprofen and an ice pack.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: Good · Site: PainFree text: My arm is less sore today (~24 hours after) than it was yesterday night (~7 hours after injection).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-12
- 2021-04-19
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-02
- 2021-05-03
- 2021-05-10
- 2021-05-19
- 2021-05-24
- 2021-06-02
- 2021-06-07
- 2021-07-26
- 2021-10-25
-
2021-12-04
Dose 3 — Moderna
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · HeadacheAdult check-in
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Gastrointestinal disorder, Headache — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, DiarrheaFree text: I think the headache and gastrointestinal issues were from work not the booster!MedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-28
-
2022-01-01
Survey response — day 28, dose 3MedDRA: Breakthrough COVID-19, Fatigue, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have a breakthrough COVID-19 infection. Symptoms are minor because of being vaxxed and boosted. Tired, runny nose, congestion, sore throat. No fever.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
- 2022-01-17
- 2022-03-07
- 2022-06-06
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Moderna | No |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Arm pain was somewhere between mild and moderate but very treatable with ibuprofen and an ice pack.
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): My arm is less sore today (~24 hours after) than it was yesterday night (~7 hours after injection).
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I think the headache and gastrointestinal issues were from work not the booster!
Release 10 — day 28, dose 3
Symptoms: I have a breakthrough COVID-19 infection. Symptoms are minor because of being vaxxed and boosted. Tired, runny nose, congestion, sore throat. No fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Gastrointestinal disorder | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release